The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of erythropoietin administered subcutaneously to AIDS
patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy.
Efficacy will be assessed by correction of anemia and decrease in transfusion requirements.